HOME >> MEDICINE >> NEWS
Important information to consider about non-systemic cholesterol lowering agents

There's been quite a bit of "noise" in the cholesterol category within the past year -- statins being recalled or relabeled due to safety concerns and future "super statins" now being called into question over safety of highest dose. And now a new compound (with no outcomes data as of yet), joins the market. What all of these compounds have in common is that they are absorbed into the blood stream.

Attached here for your review is some information about WelChol (colesevelam hydrochloride). WelChol is non-systemic (i.e., it is not absorbed and does not travel through the bloodstream.) Thus, patients may avoid systemic side effects that might accompany absorbed cholesterol-lowering drugs.

It's part of the bile acid sequestrant class -- a class that is well studied with a safety record spanning 30 years and proven outcomes data. It is also the only non-absorbed cholesterol-lowering agent FDA approved to be used in combination with any dose of any statin -- and the effects are greater then either therapy alone.

If you are doing a cholesterol story, please review the following and consider for inclusion. And please don't hesitate to contact us for further information. Thank you.

  • WelChol is non-systemic (it is not absorbed and does not travel through the bloodstream). Thus, patients may avoid systemic side effects that might accompany absorbed cholesterol-lowering drugs.

  • WelChol is the only non-systemic cholesterol-lowering agent FDA approved to be used in combination with any dose of any statin. WelChol has been studied with three top selling statins -- Lipitor, Zocor and Mevacor. Results demonstrated that co-administration of WelChol and statins can lower LDL cholesterol levels significantly better than using either therapy alone.

  • The bile acid sequestrant (BAS) class is well studied with a safety record spanning 30 years and proven outcomes data.

  • D
    '"/>


  • Contact: Deborah Adams
    dadams@hillandknowlton.com
    212-885-0449
    Hill and Knowlton
    29-Oct-2002


    Page: 1 2

    Related medicine news :

    1. Important priorities for prevention and treatment of HIV/AIDS
    2. Important advances in the development of drug delivery vehicles
    3. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
    4. Nitrosamines Play Important Role In Cancer Linked To Smoking
    5. New hand-held information system for emergency responders
    6. Clinicians report missing patient information is common
    7. Voluntary health organizations, publishers announce major information initiative
    8. Skin sterol provides new information about heart disease risk
    9. Indiana a national leader in new federal funding for health information technology
    10. New system translates improved diagnostic information to target radiation at tumors
    11. New information about heart enzymes could lead to better treatments

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
    (Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
    (Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
    (Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
    (Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
    Breaking Medicine News(10 mins):
    (Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
    (Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
    (Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
    Breaking Medicine Technology:
    Cached News: